Henning Gaissert, MD
Dr. Henning Gaissert is a thoracic surgeon at Massachusetts General Hospital in Boston, Massachusetts, and leads its department at Newton-Wellesley Hospital in Newton, Massachusetts. He has extensive experience in the use of traditional open surgery and minimally invasive surgical techniques for the treatment of lung cancer, malignant pleural mesothelioma, and other thoracic malignancies.
In addition to lung cancers, Dr. Gaissert’s clinical interests include esophageal cancer, chest wall tumors, thoracic cancers, tracheal disease, and surgical reconstruction of complex swallowing disorders.[1]
Education and Career
Dr. Gaissert’s educational journey began at the Technische Universitaet Muenchen in Munich, Germany, where he earned his medical degree. He completed an internship and residency in General Surgery at the Massachusetts General Hospital and an additional residency in Surgery at Barnes Jewish Hospital before completing fellowships in Cardiothoracic and General Surgery at Barnes Jewish Hospital and a research fellowship at Massachusetts General Hospital.[1]
After completing his medical education and training, Dr. Gaissert led the Section of Thoracic Surgery at Brown University and Rhode Island Hospital for several years before returning to practice at Massachusetts General Hospital.[1]
Professional Activities and Memberships
Dr. Gaissert is a member of several professional medical organizations, including:
- American Association for Thoracic Surgery
- Cardiothoracic Surgery Network
- European Association for Cardio-Thoracic Surgery
- General Thoracic Surgical Club
- The Society of Thoracic Surgeons
- American Board of Surgery
- American College of Surgeons (fellow)
- American College of Chest Physicians (fellow)
Research
Dr. Gaissert’s research is focused on attempting to change clinical practice and treatment for common and uncommon thoracic diseases and to inform national and international audiences about his findings.[3]
His recent publications include:[2]
Perioperative morbidity and 3-year survival in non-intubated thoracoscopic surgery: a propensity matched analysis. Udelsman BV, Jang A, Muniappan A, Zhan PL, Bao X, Chen T, Gaissert HA. J Thorac Dis. 2024 Feb 29;16(2):1180-1190. doi: 10.21037/jtd-23-591. Epub 2024 Feb 23. PMID: 38505043
Predictors of Venous Thromboembolism After Lung Cancer Resection. Axtell AL, Gaissert HA, Bao X, Auchincloss HG, Walsh E, Chang DC, Colson YL, Lanuti M. Ann Thorac Surg. 2024 Jan 29:S0003-4975(24)00014-6. doi: 10.1016/j.athoracsur.2024.01.005. Online ahead of print. PMID: 38295925
Lobectomy for Suspected Lung Cancer Without Prior Diagnosis. Onwugbufor MT, Soni ML, Predina JD, Knoll S, Hung YP, Mathisen DJ, Colson YL, Gaissert HA. Ann Thorac Surg. 2023 Oct;116(4):694-701. doi: 10.1016/j.athoracsur.2023.05.017. Epub 2023 Jun 2. PMID: 37271441
Association of Lymph Node Sampling and Clinical Volume in Lobectomy for Non-Small Cell Lung Cancer Udelsman BV, Chang DC, Boffa DJ, Gaissert HA.Ann Thorac Surg. 2023 Jan;115(1):166-173. doi: 10.1016/j.athoracsur.2022.05.051. Epub 2022 Jun 22.PMID: 35752354
Reintubation After Lung Cancer Resection: Development and External Validation of a Predictive Score. Linhardt FC, Santer P, Xu X, Gangadharan SP, Gaissert HA, Kiyatkin M, Schaefer MS, Vidal Melo MF, Eikermann M, Nagrebetsky A. Ann Thorac Surg. 2024 Jan;117(1):173-180. doi: 10.1016/j.athoracsur.2022.05.035. Epub 2022 Jun 8. PMID: 35690135
